Market Leadership PainTEQ is recognized as a leading innovator in minimally invasive SI joint procedures, with a focus on transforming chronic pain care and achieving clinical research-backed results, making it an attractive partner for healthcare providers seeking cutting-edge treatment options.

Strategic Expansion Recent product launches, including surgical instruments with LinQ technology and Surgery-Ready Instrument sets, indicate ongoing product innovation and expansion into new procedural approaches, providing opportunities to align with hospitals and clinics adopting latest minimally invasive techniques.

Strong Funding With a recent $35M non-dilutive funding round from MVolution Partners LLC, PainTEQ demonstrates significant growth capital, enabling the company to expand its market reach and invest in new technologies, which could benefit partners offering complementary devices or services.

Industry Recognition The company's repeated recognition as a Best Place to Work and inclusion in INC 5000 highlights its strong reputation and positive workplace culture, which can support a collaborative approach with potential distribution partners and strategic allies.

Market Opportunity Focusing on the niche of SI joint dysfunction and back pain treatment, PainTEQ operates in a specialized but growing segment within medical equipment manufacturing, presenting opportunities to engage with pain management clinics, orthopedic centers, and hospitals seeking innovative solutions for chronic pain treatment.